Cargando…
Impact of Opioid and Nonopioid Drugs on Postsurgical Pain Management in the Rat
Aim. Nonsteroidal anti-inflammatory drugs or opioids are commonly used to control surgical pain following veterinary and clinical procedures. This study evaluated the efficacy of postoperative ketorolac or buprenorphine following abdominal surgery. Main Methods. Mean arterial pressure (MAP), heart r...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812481/ https://www.ncbi.nlm.nih.gov/pubmed/27069684 http://dx.doi.org/10.1155/2016/8364762 |
_version_ | 1782424183057154048 |
---|---|
author | Wilson, Natalie M. Ripsch, Matthew S. White, Fletcher A. |
author_facet | Wilson, Natalie M. Ripsch, Matthew S. White, Fletcher A. |
author_sort | Wilson, Natalie M. |
collection | PubMed |
description | Aim. Nonsteroidal anti-inflammatory drugs or opioids are commonly used to control surgical pain following veterinary and clinical procedures. This study evaluated the efficacy of postoperative ketorolac or buprenorphine following abdominal surgery. Main Methods. Mean arterial pressure (MAP), heart rate, animal activity, corticosterone levels, and a nociceptive sensitivity assay were used to evaluate 18 adult male Sprague-Dawley rats which underwent aortic artery occlusion for implantation of a radiotelemetry device. The animals were treated postoperatively with intraperitoneal injections of vehicle, ketorolac (10 mg/kg), or buprenorphine (0.06 mg/kg) every 8 hours for 3 days. Key Findings. There were no consistent significant changes in any of the telemetry parameters after treatment with ketorolac compared with no saline treatment with the exception of increased MAP in the buprenorphine group during the first 48 hours when compared with other treatment groups. There was a sustained increase in fecal corticosterone levels from baseline on days 2–7 with buprenorphine compared with vehicle- or ketorolac-treated animals. All treatment conditions displayed reduced paw withdrawal thresholds (PWTs) from day 1 to day 21 following surgery. Compared with the vehicle treatment group, buprenorphine-treated animals exhibited significantly lower PWT levels from day 4 to 14 days. Significance. Given the prolonged increase in fecal corticosterone levels and pronounced changes in tactile hyperalgesia behavior in rodents subjected to buprenorphine treatment, these data suggest that ketorolac may be superior to buprenorphine for the treatment of postprocedure pain behavior in rodents. |
format | Online Article Text |
id | pubmed-4812481 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-48124812016-04-11 Impact of Opioid and Nonopioid Drugs on Postsurgical Pain Management in the Rat Wilson, Natalie M. Ripsch, Matthew S. White, Fletcher A. Pain Res Treat Research Article Aim. Nonsteroidal anti-inflammatory drugs or opioids are commonly used to control surgical pain following veterinary and clinical procedures. This study evaluated the efficacy of postoperative ketorolac or buprenorphine following abdominal surgery. Main Methods. Mean arterial pressure (MAP), heart rate, animal activity, corticosterone levels, and a nociceptive sensitivity assay were used to evaluate 18 adult male Sprague-Dawley rats which underwent aortic artery occlusion for implantation of a radiotelemetry device. The animals were treated postoperatively with intraperitoneal injections of vehicle, ketorolac (10 mg/kg), or buprenorphine (0.06 mg/kg) every 8 hours for 3 days. Key Findings. There were no consistent significant changes in any of the telemetry parameters after treatment with ketorolac compared with no saline treatment with the exception of increased MAP in the buprenorphine group during the first 48 hours when compared with other treatment groups. There was a sustained increase in fecal corticosterone levels from baseline on days 2–7 with buprenorphine compared with vehicle- or ketorolac-treated animals. All treatment conditions displayed reduced paw withdrawal thresholds (PWTs) from day 1 to day 21 following surgery. Compared with the vehicle treatment group, buprenorphine-treated animals exhibited significantly lower PWT levels from day 4 to 14 days. Significance. Given the prolonged increase in fecal corticosterone levels and pronounced changes in tactile hyperalgesia behavior in rodents subjected to buprenorphine treatment, these data suggest that ketorolac may be superior to buprenorphine for the treatment of postprocedure pain behavior in rodents. Hindawi Publishing Corporation 2016 2016-03-16 /pmc/articles/PMC4812481/ /pubmed/27069684 http://dx.doi.org/10.1155/2016/8364762 Text en Copyright © 2016 Natalie M. Wilson et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Wilson, Natalie M. Ripsch, Matthew S. White, Fletcher A. Impact of Opioid and Nonopioid Drugs on Postsurgical Pain Management in the Rat |
title | Impact of Opioid and Nonopioid Drugs on Postsurgical Pain Management in the Rat |
title_full | Impact of Opioid and Nonopioid Drugs on Postsurgical Pain Management in the Rat |
title_fullStr | Impact of Opioid and Nonopioid Drugs on Postsurgical Pain Management in the Rat |
title_full_unstemmed | Impact of Opioid and Nonopioid Drugs on Postsurgical Pain Management in the Rat |
title_short | Impact of Opioid and Nonopioid Drugs on Postsurgical Pain Management in the Rat |
title_sort | impact of opioid and nonopioid drugs on postsurgical pain management in the rat |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812481/ https://www.ncbi.nlm.nih.gov/pubmed/27069684 http://dx.doi.org/10.1155/2016/8364762 |
work_keys_str_mv | AT wilsonnataliem impactofopioidandnonopioiddrugsonpostsurgicalpainmanagementintherat AT ripschmatthews impactofopioidandnonopioiddrugsonpostsurgicalpainmanagementintherat AT whitefletchera impactofopioidandnonopioiddrugsonpostsurgicalpainmanagementintherat |